What are the side effects of Roflumilast-DALIRESP?

Roflumilast tablets (Roflumilast)-DALIRESP is a drug used to treatchronic obstructive pulmonary disease (COPD; COPD). Although it has good anti-inflammatory effects, some adverse reactions may occur during use. The more common adverse reactions observed in clinical studies include diarrhea, abdominal pain, nausea and vomiting. These digestive symptoms are often due to the effects of medications on the intestines and may cause discomfort to patients and even affect their medication compliance. In addition, decreased appetite and weight loss are also commonly reported side effects, which may be related to the patient's overall health as well as the metabolism of the drug.

In addition to digestive system problems, other common adverse reactions include headaches, dizziness, and insomnia. Headaches and dizziness may have a certain impact on the patient's daily life, while insomnia may further aggravate the patient's anxiety and discomfort. The occurrence of back and joint pain was also mentioned, and these symptoms may sometimes affect the patient's mobility and reduce their quality of life.

In rare cases, roflumilast may cause potentially serious adverse reactions. Among them, depression and suicidal ideation are the most concerning side effects, especially in patients with a history of mental illness. Such risks require more attention. Physicians should carefully assess a patient's mental health status before prescribing and regularly monitor mental status during treatment.

In addition, allergic reactions are also an aspect that requires attention, and may manifest as angioedema, rash, etc. If these symptoms occur, stop taking the medication and seek medical help immediately. For male patients, adverse reactions related to the reproductive system may also occur, such as gynecomastia, which also requires attention.

Reference materials:https://www.daliresp.com/